Cadrenal Therapeutics, Inc.

New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Jul 25, 2022
Total Offering

$2,000,000

Amount Sold

$150,000

Investors

2

First Sale

Jul 12, 2022

Offering Details

Type
Debt, Security to be Acquired, Other: 6% Convertible Note convertible into shares of common stock upon close of IPO
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Quang Pham
Related Person
Matthew Szot
Related Person

Company

Cadrenal Therapeutics, Inc.

822 A1A NORTH, SUITE 300

PONTE VEDRA, FL, 32082

(904) 300-0701

SEC Filing

0001213900-22-041222

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free